U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H8Cl2NO3S.Na.H2O
Molecular Weight 262.087
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AURICLOSENE MONOSODIUM MONOHYDRATE

SMILES

O.[Na+].CC(C)(CS([O-])(=O)=O)N(Cl)Cl

InChI

InChIKey=DZYCRLINOCERBD-UHFFFAOYSA-M
InChI=1S/C4H9Cl2NO3S.Na.H2O/c1-4(2,7(5)6)3-11(8,9)10;;/h3H2,1-2H3,(H,8,9,10);;1H2/q;+1;/p-1

HIDE SMILES / InChI

Molecular Formula C4H9Cl2NO3S
Molecular Weight 222.09
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Auriclosene (previously known as NVC-422) is a broad-spectrum, fast-acting topical anti-infective agent against microbial pathogens, including antibiotic-resistant microbes. It has been investigated in phase II clinical trials for the treatment of bacterial conjunctivitis and as a topical gel in children with impetigo. In addition, using a guinea pig model was shown, that auriclosene was effective in the treatment of dermatophytosis, including onychomycosis.

Approval Year

PubMed

PubMed

TitleDatePubMed
Broad-spectrum virucidal activity of (NVC-422) N,N-dichloro-2,2-dimethyltaurine against viral ocular pathogens in vitro.
2013-02-19
Gallium(III) complexes with 2-acetylpyridine-derived thiosemicarbazones: antimicrobial and cytotoxic effects and investigation on the interactions with tubulin.
2013-02
Evaluation of antioxidant and antimicrobial activities of essential oils from Carum copticum seed and Ferula assafoetida latex.
2013-02
Quaternary ammonium N,N-dichloroamines as topical, antimicrobial agents.
2009-05-15
Patents

Sample Use Guides

Ophthalmic solution dispensed as drops onto the eye. Auriclosene Solution 0.3% | Dermal Gel applied 3 times per day for 7 days
Route of Administration: Other
NVC-422 (AURICLOSENE) reduced the viral titer of HAdV-5, HAdV-8, HAdV-19, HAdV-37, and HSV-1 by at least 4 logs after 1 hour incubation at 250 μM. Incubation of coxsackievirus A24 and enterovirus 70 with 2.5 mM NVC-422 for 1 hour reduced the viral titer by 4 logs and 4.5 logs, respectively. The virucidal activity of NVC-422 is maintained in the presence of 10% synthetic tears. In the EpiOcular corneal tissue model, NVC-422 was nonirritating at concentrations up to 41 mM.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:25:17 GMT 2025
Edited
by admin
on Mon Mar 31 18:25:17 GMT 2025
Record UNII
4787JWS9HN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NVC-422 MONOSODIUM MONOHYDRATE
Preferred Name English
AURICLOSENE MONOSODIUM MONOHYDRATE
Common Name English
SODIUM 2-(DICHLOROAMINO)-2-METHYLPROPANE-1-SULPHONATE HYDRATE
Systematic Name English
1-PROPANESULFONIC ACID, 2-(DICHLOROAMINO)-2-METHYL-, SODIUM SALT, MONOHYDRATE
Common Name English
SODIUM 2-(DICHLOROAMINO)-2-METHYLPROPANE-1-SULFONATE MONOHYDRATE
Systematic Name English
AL-46383A
Code English
Code System Code Type Description
FDA UNII
4787JWS9HN
Created by admin on Mon Mar 31 18:25:17 GMT 2025 , Edited by admin on Mon Mar 31 18:25:17 GMT 2025
PRIMARY
PUBCHEM
76964366
Created by admin on Mon Mar 31 18:25:17 GMT 2025 , Edited by admin on Mon Mar 31 18:25:17 GMT 2025
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY